Notably, elevated SOX2 expression has been reported to promote tumorigenesis and metastasis in osteosarcoma, while SOX2 inhibition can ameliorate these malignant phenotypes (Chen et al., 2023; Wang et al., 2024). This evidence concerns the gene SOX2 and osteosarcoma.